Bristol Myers Shedding 2,200 Jobs in Cost Savings Push
By Colin Kellaher
Bristol Myers Squibb on Thursday said it plans to cut more than 2,000 jobs as part of an initiative aimed at generating about $1.5 billion in cost savings by the end of next year.
The Princeton, N.J., biopharmaceutical company plans to reinvest the bulk of the savings to fund innovation and drive growth, and will focus its resources on research-and-development programs with the potential to deliver the greatest return on investment.
Bristol Myers said the initiative, which will affect roughly 2,200 employees this year, includes a reduction of management layers, a pipeline rationalization, site consolidation and reduced third-party spending.
The company currently has more than 34,000 employees, according to data from FactSet.
Bristol Myers said it will prioritize investments in key growth brands while optimizing operations across the organization.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
April 25, 2024 08:51 ET (12:51 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
3 Stocks to Buy and 3 Stocks to Sell After Earnings
-
Markets Brief: Is It Really a Surprising Quarter for Earnings?
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
What I Hope My 14-Year-Old Learned at Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Amazon Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Dividend Stocks
-
3 Stocks With High Dividend Yields That Warren Buffett Likes
-
How to Invest Like Warren Buffett
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?